Nicotine and serotonin in immune regulation and inflammatory processes: A perspective

Journal of Leukocyte Biology

Volumn 81, Issue 3, 2007, Pages 599-606

  Cloëz Tayarani, Isabelle ^a,b   Changeux, Jean Pierre ^a  

^a CNRS   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

5 HT receptors; Cytokine; Immune cells; Inflammation; Neuromodulator; Nicotinic cholinergic receptors

Indexed keywords

ACETYLCHOLINE; NICOTINE; NICOTINIC RECEPTOR; SEROTONIN; SEROTONIN RECEPTOR; TUMOR NECROSIS FACTOR;

B LYMPHOCYTE; BLOOD CELL; CYTOKINE RELEASE; DENDRITIC CELL; DRUG EFFECT; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; CYTOKINES; HUMANS; IMMUNITY; INFLAMMATION; NICOTINE; SEROTONIN; SIGNAL TRANSDUCTION;

MUS;

EID: 33847796935     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0906544     Document Type: Review

References (81)

1. Pomerleau, O. F., Turk, D. C., Fertig, J. B. (1984) The effects of cigarette smoking on pain and anxiety. Addict. Behav. 9, 265-271.
2. Cheeta, S., Irvine, E. E., Kenny, P. J., File, S. E. (2001) The dorsal raphe nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses. Psychopharmacology (Berl.) 155, 78-85.
3. File, S. E., Cheeta, S., Kenny, P. J. (2000) Neurobiological mechanisms by which nicotine mediates different types of anxiety. Eur. J. Pharmacol. 393, 231-236.
4. Verbeuren, T. J., Jordaens, F. H., Herman, A. G. (1983) Accumulation and release of (3H)-5-hydroxytryptamine in saphenous veins and cerebral arteries of the dog. J. Pharmacol. Exp. Ther. 226, 579-588.
5. Sopori, M. L., Kozak, W., Savage, S. M., Geng, Y., Soszynski, D., Kluger, M. J., Perryman, E. K., Snow, G. E. (1998) Effects of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms. Psychoneuroendocrinology 23, 189-204.
6. Benowitz, N. L. (1988) Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition. N. Engl. J. Med. 319, 1318-1330.
7. Fagerstrom, K. O., Hughes, J. R. (2002) Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: a review. Nicotine Tob. Res. 4 (Suppl. 2), S73-S79.
8. Kawashima, K., Fujii, T. (2000) Extraneuronal cholinergic system in lymphocytes. Pharmacol. Ther. 86, 29-48.
9. Czura, C. J., Tracey, K. J. (2005) Autonomic neural regulation of immunity. J. Intern. Med. 257, 156-166.
10. Pavlov, V. A., Tracey, K. J. (2005) The cholinergic anti-inflammatory pathway. Brain Behav. Immun. 19, 493-499.
11. Huston, J. M., Ochani, M., Rosas-Ballina, M., Liao, H., Ochani, K., Pavlov, V. A., Gallowitsch-Puerta, M., Ashok, M., Czura, C. J., Foxwell, B., Tracey, K. J., Ulloa, L. (2006) Splenectomy inactivates the cholinergic anti-inflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J. Exp. Med. 203, 1623-1628.
12. Mossner, R., Lesch, K. P. (1998) Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav. Immun. 12, 249-271.
13. Askenase, P. W., Szczepanik, M., Itakura, A., Kiener, C., Campos, R. A. (2004) Extravascular T-cell recruitment requires initiation begun by Vα14+ NKT cells and B-1 B cells. Trends Immunol. 25, 441-449.
14. Lechin, F. (2000) Central and plasma 5-HT, vagal tone and airways. Trends Pharmacol. Sci. 21, 425.
15. O'Connell, P. J., Wang, X., Leon-Ponte, M., Griffiths, C., Pingle, S. C., Ahern, G. P. (2006) A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood 107, 1010-1017.
16. Racke, K., Schworer, H., Simson, G. (1992) Effects of cigarette smoking or ingestion of nicotine on platelet 5-hydroxytryptamine (5-HT) levels in smokers and non-smokers. Clin. Investig. 70, 201-204.
17. Rausch, J. L., Fefferman, M., Ladisich-Rogers, D. G., Menard, M. (1989) Effect of nicotine on human blood platelet serotonin uptake and efflux. Prog. Neuropsychopharmacol. Biol. Psychiatry 13, 907-916.
18. Schwartz, K., Weizman, A., Rehavi, M. (2005) Decreased platelet vesicular monoamine transporter density in habitual smokers. Eur. Neuropsychopharmacol. 15, 235-238.
19. Schworer, H., Racke, K., Kilbinger, H. (1987) Cholinergic modulation of the release of 5-hydroxytryptamine from the guinea-pig ileum. Naunyn Schmiedebergs Arch. Pharmacol. 336, 127-132.
20. Minami, M., Endo, T., Hirafuji, M., Hamaue, N., Liu, Y., Hiroshige, T., Nemmoto, M., Saito, H., Yoshioka, M. (2003) Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity. Pharmacol. Ther. 99, 149-165.
21. Calkins, B. M. (1989) A meta-analysis of the role of smoking in inflammatory bowel disease. Dig. Dis. Sci. 34, 1841-1854.
22. Pullan, R. D. (1994) Transdermal nicotine for active ulcerative colitis. N. Engl. J. Med. 330, 811-815.
23. Coates, M. D., Mahoney, C. R., Linden, D. R., Sampson, J. E., Chen, J., Blaszyk, H., Crowell, M. D., Sharkey, K. A., Gershon, M. D., Mawe, G. M., Moses, P. L. (2004) Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126, 1657-1664.
24. Wirleitner, B., Neurauter, G., Schrocksnadel, K., Frick, B., Fuchs, D. (2003) Interferon-γ-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. Curr. Med. Chem. 10, 1581-1591.
25. Pellegrin, K., Neurauter, G., Wirleitner, B., Fleming, A. W., Peterson, V. M., Fuchs, D. (2005) Enhanced enzymatic degradation of tryptophan by indoleamine 2,3-dioxygenase contributes to the tryptophan-deficient state seen after major trauma. Shock 23, 209-215.
26. Grohmann, U., Fallarino, F., Puccetti, P. (2003) Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol. 24, 242-248.
27. Alkondon, M., Pereira, E. F., Yu, P., Arruda, E. Z., Almeida, L. E., Guidetti, P., Fawcett, W. P., Sapko, M. T., Randall, W. R., Schwarcz, R., Tagle, D. A., Albuquerque, E. X. (2004) Targeted deletion of the kynurenine aminotransferase II gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via α7 nicotinic receptors in the hippocampus. J. Neurosci. 24, 4635-4648.
28. Changeux, J. P., Bertrand, D., Corringer, P-J., Dehaene, S., Edelstein, S., Lena, C., Le Novère, N., Marubio, L., Picciotto, M., Zoli, M. (1998) Brain nicotinic receptors: structure and regulation, role in learning and reinforcement. Brain Res. Brain Res. Rev. 26, 198-216.
29. Champtiaux, N., Changeux, J. P. (2004) Knockout and knockin mice to investigate the role of nicotinic receptors in the central nervous system. Prog. Brain Res. 145, 235-251.
30. Changeux, J. P., Edelstein, S. J. (2005) Allosteric mechanisms of signal transduction. Science 308, 1424-1428.
31. (2006) Nicotinic Acetylcholine Receptors (J. P. Changeux, S. J. Edelstein, eds.), Paris, France, Odile Jacob.
32. Taly, A., Delarue, M., Grutter, T., Nilges, M., Le Novère, N., Corringer, P-J., Changeux, J-P. (2005) Normal mode analysis suggests a quaternary twist model for the nicotinic receptor gating mechanism. Biophys. J. 88, 3954-3965.
33. Wang, H., Yu, M., Ochani, M., Amelia, C. A., Tanovic, M., Susurla, S., Li, J. H., Wang, H., Yang, H., Ulloa, L., Al-Abed, Y., Czura, C. J., Tracey, K. J. (2003) Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 421, 384-388.
34. Middlebrook, A. J., Martina, C., Chang, Y., Lukas, R. J., DeLuca, D. (2002) Effects of nicotine exposure on T cell development in fetal thymus organ culture: arrest of T cell maturation. J. Immunol. 169, 2915-2924.
35. Skok, M. V., Kalashnik, E. N., Koval, L. N., Tsetlin, V. I., Utkin, Y. N., Changeux, J-P., Grailhe, R. (2003) Functional nicotinic acetylcholine receptors are expressed in B lymphocyte-derived cell lines. Mol. Pharmacol. 64, 885-889.
36. Skok, M., Grailhe, R., Changeux, J-P. (2005) Nicotinic receptors regulate B lymphocyte activation and immune response. Eur. J. Pharmacol. 517, 246-251.
37. Skok, M., Grailhe, R., Agenes, F., Changeux, J-P. (2006) The role of nicotinic acetylcholine receptors in lymphocyte development. J. Neuroimmunol. 171, 86-98.
38. Hawkins, B. T., Brown, R. C., Davis, T. P. (2002) Smoking and ischemic stroke: a role for nicotine? Trends Pharmacol. Sci. 23, 78-82.
39. Sallette, J., Pons, S., Devillers-Thiery, A., Soudan, M., Prado de Cavalho, L., Changeux, J-P., Corringer, J-P. (2005) Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron 46, 595-607.
40. Wonnacott, S. (1990) The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol. Sci. 11, 216-219.
41. Buisson, B., Bertrand, D. (2002) Nicotine addiction: the possible role of functional upregulation. Trends Pharmacol. Sci. 23, 130-136.
42. Gentry, C. L., Lukas, R. J. (2002) Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure. Curr. Drug Targets CNS Neurol. Discord. 1, 359-385.
43. Corringer, P-J., Sallette, J., Changeux, J-P. (2006) Nicotine enhances intracellular nicotinic receptor maturation: a novel mechanism of neural plasticity? J. Physiol. (Paris) 99, 162-171.
44. Cormier, A., Paas, Y., Zini, R., Tillement, J-P., Lagrue, G., Changeux, J-P., Grailhe, R. (2004) Long-term exposure to nicotine modulates the level and activity of acetylcholine receptors in white blood cells of smokers and model mice. Mol. Pharmacol. 66, 1712-1718.
45. Hoyer, D., Hannon, J. P., Martin, G. R. (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 71, 533-554.
46. (2006) The Serotonin Receptors, from Molecular Pharmacology to Human Therapeutics (B. L. Roth, eds.), Totowa, NJ, Humana.
47. Adayev, T., Ranasinghe, B., Banerjee, P. (2005) Transmembrane signaling in the brain by serotonin, a key regulator of physiology and emotion. Biosci. Rep. 25, 363-385.
48. Idzko, M., Panther, E., Stratz, C., Muller, T., Bayer, H., Zissel, G., Durk, T., Sorichter, S., DiVirgilio, F., Geissler, M., Fiebich, B., Herouy, Y., Elsner, P., Norgauer, J., Ferrari, D. (2004) The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J. Immunol. 172, 6011-6019.
49. 1A-mediated promotion of mitogen-activated T and B cell survival and proliferation is associated with increased translocation of NF-κB to the nucleus. Brain Behav. Immun. 18, 24-34.
50. Cloëz-Tayarani, I., Petit-Bertron, A. F., Venters, H. D., Cavaillon, J. M. (2003) Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors. Int. Immunol. 15, 233-240.
51. Foon, K. A., Wahl, S. M., Oppenheim, J. J., Rosenstreich, D. L. (1976) Serotonin-induced production of a monocyte chemotactic factor by human peripheral blood leukocytes. J. Immunol. 117, 1545-1552.
52. Fiebich, B. L., Akunda, R. S., Lieb, K., Candelario-Jalil, E., Gmeimer, D., Haus, U., Muller, W., Stratz, T., Munoz, E. (2004) Expression of 5-HT3A receptors in cells of the immune system. Scand. J. Rheumatol. Suppl. 119, 9-11.
53. Pavlov, V. A., Wang, H., Czura, C. J., Friedman, S. G., Tracey, K. J. (2003) The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol. Med. 9, 125-134.
54. Saeed, R. W., Varma, S., Peng-Nemeroff, T., Sherry, B., Balakhaneh, D., Huston, J., Tracey, K. J., Al-abed, Y., Metz, C. N. (2005) Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J. Exp. Med. 201, 1113-1123.
55. Nizri, E., Hamra-Amitay, Y., Sicsic, C., Lavon, I., Brenner, T. (2006) Anti-inflammatory properties of cholinergic up-regulation: a new role for acetylcholinesterase inhibitors. Neuropharmacology 50, 540-547.
56. Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., Tracey, K. J. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458-462.
57. Pavlov, V. A., Ochani, M., Gallowitsch-Puerta, M., Ochani, K., Huston, J. M., Czura, C. J., Al-Abed, Y., Tracey, K. J. (2006) Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc. Natl. Acad. Sci. USA 103, 5219-5223.
58. Matsunaga, K., Klein, T. W., Friedman, H., Yamamoto, Y. (2001) Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J. Immunol. 167, 6518-6524.
59. Nouri-Shirazi, M., Guinet, E. (2003) Evidence for the immunosuppressive role of nicotine on human dendritic cell functions. Immunology 109, 365-373.
60. Banchereau, J., Steinman, R. M. (1998) Dendritic cells and the control of immunity. Nature 392, 245-252.
61. Janson, C., Chinn, S., Jarvis, D., Zock, J-P., Torén, K., Burney, P. (2001) Effect of passive smoking on respiratory symptoms, bronchial responsiveness, lung function, and total serum IgE in the European Community Respiratory Health Survey: a cross-sectional study. Lancet 358, 2103-2109.
62. Blanchet, M. R., Israël-Assayag, E., Cormier, Y. (2004) Inhibitory effect of nicotine on experimental hypersensitivity pneumonitis in vivo and in vitro. Am. J. Respir. Crit. Care Med. 169, 903-909.
63. Ouyang, Y., Virasch, N., Hao, P., Aubrey, M. T., Mukerjee, N., Bierer, B. E., Freed, B. M. (2000) Suppression of human IL-1β, IL-2, IFN-γ, and TNF-γ production by cigarette smoke extracts. J. Allergy Clin. Immunol. 106, 280-287.
64. Hakki, A., Hallquist, N., Friedman, H., Pross, S. (2000) Differential impact of nicotine on cellular proliferation and cytokine production by LPS-stimulated murine splenocytes. Int. J. Immunopharmacol. 22, 403-410.
65. Dürk, T., Panther, E., Müller, T., Sorichter, S., Ferrari, D., Pizzirani, C., Di Virgilio, F., Myrtek, D., Norgauer, J., Idzko, M. (2005) 5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes. Int. Immunol. 17, 599-606.
66. Billiau, A., Heremans, H., Vermeire, K., Matthys, P. (1998) Immunomodulatory properties of interferon-γ. An update. Ann. N. Y. Acad. Sci. 856, 22-32.
67. Packard, K. A., Khan, M. M. (2003) Effects of histamine on Th1/Th2 cytokine balance. Int. Immunopharmacol. 3, 909-920.
68. Madretsma, S., Wolters, L. M., Van Dick, J. P., Tak, C. J., Wilson, J. H., Zijlstra, F. J. (1996) In vivo effect of nicotine on cytokine production by human non-adherent mononuclear cells. Eur. J. Gastroenterol. Hepatol. 8, 1017-1020.
69. Vohra, P. (2000) Inflammatory bowel disease. Indian J. Pediatr. 67, 747-756.
70. Geng, Y., Savage, S. M., Razani-Boroujerdi, S., Sopori, M. L. (1996) Effects of nicotine on the immune response. II Chronic nicotine treatment induces T cell anergy. J. Immunol. 156, 2384-2390.
71. McAllister-Sistilli, C. G., Caggiula, A. R., Knof, S., Rose, C. R., Miller, A. L., Donny, E. C. (1998) The effects of nicotine on the immune system. Psychoneuroendocrinology 23, 175-187.
72. Hallquist, N., Hakki, A., Wecker, L., Friedman, H., Pross, S. (2000) Differential effects of nicotine and aging on splenocyte proliferation and the production of Th1-versus Th2-type cytokines. Proc. Soc. Exp. Biol. Med. 224, 141-146.
73. Wang, H., Liao, H., Ochani, M., Justiniani, M., Lin, X., Yang, L., Al-abed, Y., Wang, H., Metz, C., Miller, E. J., Tracey, K. J., Ulloa, L. (2004) Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10, 1216-1221.
74. Mai, H., May, W. S., Gao, F., Jin, Z., Deng, X. (2003) A functional role for nicotine in Bcl2 phosphorylation and suppression of apoptosis. J. Biol. Chem. 278, 1886-1891.
75. Chen, Y. C., Shen, S-C., Lin, H-Y., Tsai, S-H., Lee, T. J. F. (2004) Nicotine enhancement of lipopolysaccharide/interferon-γ-induced cytotoxicity with elevating nictric oxide production. Toxicol. Lett. 153, 191-200.
76. Raison, C. L., Capuron, L., Miller, A. H. (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27, 24-31.
77. Maleki, N., Nayebi, A. M., Garjani, A. (2005) Effects of central and peripheral depletion of serotonergic system on carrageenan-induced paw oedema. Int. Immunopharmacol. 5, 1723-1730.
78. Schuff-Werner, P., Splettstoesser, W. (1999) Antioxidative properties of serotonin and the bactericidal function of polymorphonuclear phagocytes. Adv. Exp. Med. Biol. 467, 321-325.
79. Metz, C. N., Tracey, K. J. (2005) It takes nerve to dampen inflammation. Nat. Immunol. 6, 756-767.
80. 1A receptor mRNA and protein in activated B and T lymphocytes. J. Biol. Chem. 276, 4382-4388.
81. Vega L de, L., Munoz, E., Calzado, M. A., Lieb, K., Candelario-jalil, E., Gschaidmeir, H., Färber, L., Mueller, W., Stratz, T., Fiebich, B. L. (2005) The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway. Biochem. Pharmacol. 70, 369-380.